Matthew A J Duncton

6PUBLICATIONS
18CO-AUTHORS
Biologically active moleculesCheminformatics and quantitative structure-activity relationshipsMolecular targetsOrganometallic chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 20, 2023
Tuning the Reactivity of Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators for Optimal <i>in Vivo</i> Efficacy.

Vadim Markovtsov, Matthew A J Duncton, Art Bagos

|Dec 09, 2023
A New Drug Discovery Platform: Application to DNA Polymerase Eta and Apurinic/Apyrimidinic Endonuclease 1.

Debanu Das, Matthew A J Duncton, Taxiarchis M Georgiadis

|Oct 11, 2023
Development of a MEK inhibitor, NFX-179, as a chemoprevention agent for squamous cell carcinoma.

Kavita Y Sarin, John Kincaid, Brittney Sell

|Sep 15, 2020
A Single-Step Synthesis of Azetidine-3-amines.

Brian J Wang, Matthew A J Duncton

|Oct 09, 2018
Orally Absorbed Derivatives of the β-Lactamase Inhibitor Avibactam. Design of Novel Prodrugs of Sulfate Containing Drugs.

Eric M Gordon, Matthew A J Duncton, Mark A Gallop

|Mar 15, 2017
Enantioselective synthesis of an octahydroindolizine (indolizidine) alcohol using an enzymatic resolution.

Jing Zhang, Rao Kolluri, Salvador G Alvarez

Pageof 1

Frequent Collaborators

1 joint publications

Eric M Gordon

1 joint publications

Kavita Y Sarin

1 joint publications

John Kincaid

1 joint publications

Brittney Sell